The global montelukast intermediate market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors responsible for the growth of the market during the forecast period include an increase in demand for the montelukast intermediate from API (Active Pharmaceutical Ingredient) manufacturers, an increase in presence of generics as well as rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria.
The montelukast intermediates are used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma. Moreover, montelukast is designated for the handling of periodic and recurrent allergic rhinitis. The important aspects pouring the market’s evolution include globally rising commonness of allergic rhinitis, urticaria, asthma, bronchospasm, burgeoning pharmaceutical industry attached with the rising call from active pharmaceutical ingredients (APIs) manufacturers, and montelukast patent expiration.
To Request a Sample of our Report on Global Montelukast Intermediate Market: https://www.omrglobal.com/request-sample/montelukast-intermediate-market
The global montelukast intermediate market analysis includes some of the key market players such as Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., and Merck & Co., Inc., among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in November 2020, Mylan received clearance from the US Federal Trade Commission (FTC) to advance the merger of Pfizer’s Upjohn generics unit.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., and Merck & Co., Inc., among others.
A full Report of Global Montelukast Intermediate Market is Available @ https://www.omrglobal.com/industry-reports/montelukast-intermediate-market
Global Montelukast Intermediate Market Report by Segment
By Application
- Asthma
- Allergic Rhinitis
- Bronchospasm
- Urticaria
Global Montelukast Intermediate Market by Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/montelukast-intermediate-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
